Magnetar Financial’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Magnetar Financial’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,017,446	Closed	-$72.3M	–	782
2020 Q2	$72.3M	Buy	+4,017,446	New	+$55.9M	2.13%	12
2018 Q4	–	Sell	-15,000	Closed	-$399K	–	573
2018 Q3	$399K	Sell	15,000 -21,323	-59%	-$696K	0.01%	242
2018 Q2	$1.37M	Buy	+36,323	New	+$1.39M	0.02%	111

Magnetar Financial's PTLA Position: Q3 2020 in Review

Magnetar Financial sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 4,017,446 shares — an estimated $72.3M sold.

Magnetar Financial first reported a position in PTLA in Q2 2018 and held it in 3 quarters. The position peaked at $72.3M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Magnetar Financial reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Magnetar Financial sold 4,017,446 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $72.3M.
Magnetar Financial first reported a position in Portola Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
Magnetar Financial's Portola Pharmaceuticals, Inc. position peaked at $72.3M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Magnetar Financial's 13F filing for Q3 2020, filed 16 Nov 2020.